Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
52,664,292
-
Total 13F shares
-
635,782
-
Share change
-
+34,017
-
Total reported value
-
$3,270,005
-
Price per share
-
$5.13
-
Number of holders
-
15
-
Value change
-
+$172,217
-
Number of buys
-
6
-
Number of sells
-
3
Institutional Holders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) as of Q2 2019
As of 30 Jun 2019,
Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
635,782 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, DIMENSIONAL FUND ADVISORS LP, MILLENNIUM MANAGEMENT LLC, JPMORGAN CHASE & CO, and MORGAN STANLEY.
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.